Multiplex Assays Market Size & Share To Surpass USD 5.9 Billion By 2031 | Analysis By Transparency Market Research, Inc.
Multiplex Assays Market Size & Share To Surpass USD 5.9 Billion By 2031 | Analysis By Transparency Market Research, Inc. . (MENAFN - GlobeNewsWire - Nasdaq) Currently, the overall demand for medicines for autoimmune diseases is increasing. The main reason behind this is the health awareness among consumers. Also, it can ...
América - MenaFN
(MENAFN- GlobeNewsWire - Nasdaq) Currently, the overall demand for medicines for autoimmune diseases is increasing. The main reason behind this is the awareness among consumers. Also, it can be evident that detecting pathogens and viruses becomes extremely crucial.

Wilmington, Delaware, United States, Transparency Research -, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global multiplex assays market ( 멀티플렉스 분석 시장 ) is estimated to be valued at US$ 5.9 billion by 2031 . As of 2022, the market valuation turned out to be US$ 3.2 billion . This is expected to rise at a moderate CAGR of 6.9% . Various forces might be responsible for such a growth rate of the market.

Multiplexed point-of-care testing has been emerging. It simultaneously detects various analytes at a particular site. Due to this, a single specimen is tested more easily and in less time. Consequently, this enhances the efficiency of testing. As a result, the demand for the same is constantly rising. This creates an assertive market force that heavily drives the market under consideration, leading it to moderate growth.

In the contemporary medical field, multiplex immunoassays are employed on a large scale. It helps medical professionals to detect the presence of antibodies in humans. These autoantibodies generated can be seen simultaneously, which enhances the efficiency of medical testing. Additionally, the prevalence of autoimmune diseases has been rising, which creates a crucial market driver for the subject market.

Download sample PDF copy of report:









The cost-effectiveness of multiplex assays is more than that of singleplex assays. The main reason is the high output-per-volume ratio delivered by multiplex assays. Also, due to the limited conservation of sample volume, the target accuracy is enhanced. This adds value to multiplex assays, proving to be a positive market force.

Key Findings from the Market Report



The global multiplex assay market is segmented based on product type, the technology used, the type of ingredient, its application, and the end-user industry. The consumable market segment uses edible products that form a substantial market segment area.

Multiplex RT-PCR is the market segment that amplifies multiple target sequences. This allows the user to enrich the target by amplifying.

The protein assay market segment generates knowledge regarding the concentration level of an array of proteins in the body. Research development is another crucial market segment that signifies the development of the existing structure of multiplex assays.

Key Developments in the Multiplex Assays Market



In February 2023 , real-time PCR kits were launched by Thermo Fisher Scientific in India to arrest and detect the presence of infectious diseases.

In September 2023, GT Molecular, Inc. partnered with F. Hoffmann-La Roche AG. These organizations' strategic alliances helped them gain more competitive space within the market. In November 2023, DiaSorin S.p.A. collaborated with Gilead Sciences. This collaboration resulted in developing a fully automated diagnostic assay for the hepatitis delta virus.

Competitive Landscape

The competitive landscape of the global multiplex assays market is coarse. There are various players within the market.



DiaSorin S.p.A . is one of the key players known for its molecular diagnostics technology. Also, it offers instruments for the same. Additionally, it provides immunodiagnostics.

In the case of Thermo Fisher Scientific, Inc., the medical organization provides various laboratory instruments. Additionally, it gives pipettes, burettes, and many other products. Abcam Limited is known for supplying antibodies for clinical applications. It also offers antibodies for research purposes. It offers immunoassays that are essential to the organization's product portfolio.

Key Players



DiaSorin S.p.A.

Thermo Fisher Scientific Inc.

Seegene Inc.

Meso Scale Diagnostics LLC

Abcam Limited

Bio-Rad Laboratories Inc.

QIAGEN

Merck KGaA

Quansys Biosciences Illumina Inc.

Regional Profile



In the case of North America , a large number of market players working in the global multiplex assays market can be found. Due to this, the scope of growth of the market in the particular region is more. Further, the medical infrastructure in countries like Canada and the USA has grown. Thus, it proves to be the largest contributor to the subject market.

Similarly, Europe has also developed medical infrastructure, which fuels R&D related to multiplex assays. Therefore, Europe contributes substantially to the subject market, securing a respectable market share. Apart from this, Asia Pacific, Africa , and the Middle East are some regions that contribute to the market growth under consideration.

Unlock Growth Potential in Your Industry! Download PDF Brochure:

Market Segmentation

Product



Instruments Consumables



Reagents & Kits

Micropipettes & Microplates Others

Software

Technology



Multiplex RT-PCR

Flow Cytometry

Luminescence

Fluorescence Others

Type

Protein



Planar Bead-based

Nucleic Acid



Planar Bead-based

Cell

Application

Research & Development



Drug Discovery & Research Biomarker Research & Application

Diagnosis



Infectious Diseases

Autoimmune Diseases

Cancer

Cardiovascular Diseases

Neuroendocrine Diseases Others

Others

End User



Biotechnology & Biopharmaceutical Companies

Academic & Research Centers

Diagnostic Centers

Hospitals Others

Region



North America

Europe

Asia Pacific

Middle East & Africa South America

Buy this Premium Research Report @

More Trending Reports by Transparency Market Research –

Endodontic Consumables Market (歯内療法用消耗品市場) - The market was valued at US$ 1.1 Bn in 2021 and it is estimated to grow at a CAGR of 4.5% from 2022 to 2031 and reach US$ 1.6 Bn by the end of 2031

Virtual Clinical Trials Market (سوق التجارب السريرية الافتراضية) - The industry was valued at US$ 7.6 Bn in 2021 and it is estimated to advance at a CAGR of 7.4 % from 2022 to 2032 and reach US$ 16.4 Bn by the end of 2032

About Transparency Market Research

Transparency Market Research , a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact :

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free : 866-552-3453

Website:

Email: ...

Follow Us: LinkedIn | Twitter | Blog | YouTube
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108847073/Multiplex-Assays-Market-Size-Share-To-Surpass-USD-59-Billion-By-2031-Analysis-By-Transparency-Market-Research-Inc
2024-11-04
rss
(MENAFN - GlobeNewsWire - Nasdaq) Currently, the overall demand for medicines for autoimmune diseases is increasing. The main reason behind this is the health awareness among consumers. Also, it can ...
Multiplex Assays Market Size & Share To Surpass USD 5.9 Billion By 2031 | Analysis By Transparency Market Research, Inc.